Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 K Wave Media KWM Feb 6, 2026 0.77 +2.60   
 K&f Growth Acquisition II A KFII Feb 6, 2026 10.43 0.00   
 K-Tech Solutions KMRK Feb 6, 2026 1.78 -1.66   
 K2 Capital Acquisition Unit KTWOU Feb 6, 2026 10.06 0.00   
 Kadant KAI Feb 6, 2026 343.11 +3.89   
 Kairos Pharma KAPA Feb 6, 2026 0.62 +4.24   
 Kaiser Aluminium KALU Feb 6, 2026 138.51 +5.72   
 Kaival Brands Innovations Group KAVL Feb 6, 2026 0.14 0.00   
 Kaixin Holdings KXIN Feb 6, 2026 0.88 +14.29   
 Kala Bio KALA Feb 6, 2026 0.44 +10.28   
 Kalaris Therapeutics KLRS Feb 6, 2026 8.34 -0.12   
 Kaltura KLTR Feb 6, 2026 1.39 +2.96   
 KalVista Pharmaceuticals KALV Feb 6, 2026 14.90 +3.47   
 Kamada KMDA Feb 6, 2026 8.21 +2.37   
 Kandal M Venture A FMFC Feb 6, 2026 0.32 +1.27   
 Kandi Technologies Group KNDI Feb 6, 2026 1.07 +0.94   
 Kanzhun ADR BZ Feb 6, 2026 17.92 +2.46   
 Karat Packaging KRT Feb 6, 2026 25.85 +0.94   
 Karbon Capital Partners KBON Feb 6, 2026 10.06 0.00   
 Karbon Capital Partners Unit KBONU Feb 6, 2026 10.23 0.00   
 Karman KRMN Feb 6, 2026 95.36 +6.22   
 Karooooo KARO Feb 6, 2026 49.99 +4.32   
 Kartoon Studios TOON Feb 6, 2026 0.70 +1.14   
 Karyopharm Therapeutics KPTI Feb 6, 2026 6.26 +2.79   
 Katapult KPLT Feb 6, 2026 6.66 +11.00   
 Kayne Anderson BDC KBDC Feb 6, 2026 14.06 +0.64   
 Kayne Anderson Energy Infrastructure Fund KYN Feb 6, 2026 13.40 +1.21   
 Kazia Therapeutics ADR KZIA Feb 6, 2026 5.79 +3.02   
 KB Financial Group ADR KB Feb 6, 2026 104.63 +8.81   
 KB Home KBH Feb 6, 2026 60.94 -1.09   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.